Bookmark

Add to MyYahoo RSS

Johnson and Johnson News

News on Johnson and Johnson (Ticker: JNJ) continually updated from thousands of sources around the net.

4 hrs ago | Business Times

Analysts point to new phase of bull market

Searching for yield: Traders sold highfliers such as Google in the wake of their earnings and rotated into companies that reported steadier - if less spectacular - growth, such as General Electric and Johnson & Johnson.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Financial Markets

12 hrs ago | The Motley Fool

Why Low-Volatility Stocks Might Not Work in the Next Crash

One strategy that many investors use to protect themselves against pullbacks is to focus on stocks that have lower volatility than the overall market, counting on them to fall more gently than the S&P 500 in the event of trouble.

Comment?

Related Topix: Financial Markets, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

18 hrs ago | The Spokesman-Review

Motley Fool: Put Johnson & Johnson in long-term portfolio - Sun, 20 Apr 2014 PST

Big blue-chip companies might not grow rapidly, but they can offer more stability than smaller counterparts, and they often pay dividends, too.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Tylenol, Tempra, Acetaminophen (generic), Prostate Cancer, Health, Rheumatoid Arthritis, Arthritis, Food and Drug Administration

22 hrs ago | Seeking Alpha

Why Johnson & Johnson's Patent Expiration Profile Is Fantastic

Johnson & Johnson boasts a cash-flow-derived Valuentum Dividend Cushion score of 2.2, and we don't see us removing it from the Dividend Growth portfolio anytime soon.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Sat Apr 19, 2014

The Motley Fool

Johnson & Johnson's Headache-Fixing Earnings, Mattel's Un-Fun Earnings, and Why Stocks Popped All We

Time to take a break from stuffing your face with Cadbury Creme Eggs. Although the stock market was closed for Good Friday, the S&P 500 rose all four days during the holiday-shortened week, which was chock-full of earnings reports.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Financial Markets

Gawker

Insanely Rich Reporter Covers White House Meeting of the Insanely Rich

There's a lot to pore over in the New York Times Style section's coverage of a conference for ber-wealthy "next-generation" philanthropists that was recently held at the White House.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Fri Apr 18, 2014

BioSpace

Johnson & Johnson Starts Construction On $300 Million China Plant

For J&J, the new facility is its biggest single investment in a plant and its largest production facility .

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

PR-inside.com

Belgium digestive remedies market: Janssen-Cilag the dominant industry player during 2012

Janssen-Cilag was the undisputed leader in a fragmented competitive environment in the Belgium digestive remedies market in 2012.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Seeking Alpha

My Top Company For Income And Capital Gains

Once again, Johnson & Johnson has come through for investors. The company just reported a very solid first-quarter earnings report.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Thu Apr 17, 2014

Investopedia

How Some Brands Come Back from Near Death

Some brands - Pan Am, Montgomery Ward - once carried considerable cachet, only to lose traction and never recover.

Comment?

Related Topix: Procter and Gamble, Household Products, Marketing, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

Bloomberg

FDA Discourages Common Uterine Procedure on Cancer Threat

The U.S. Food and Drug Administration is warning doctors against using a popular method to remove the uterus or uterine fibroids without open surgery because it can spread cancer cells.

Comment?

Related Topix: Food and Drug Administration, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, US News

Examiner.com

How your green business can encourage consumers to recycle

Nearly three-quarters of consumers consistently recycle in the home, but only about half do so in rooms beyond the kitchen.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

The Washington Post

The role of your gut in allergies

Sneezes may be the result of bacteria in your gut. The Human Microbiome Project is a bold attempt to understand how all the microorganisms in the human body contribute to health problems such as allergic reactions.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Johnson & Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Genetics, Entertainment

JD Supra

Dallas Woman Awarded $1.2 Million, Mesh Called Defectively Designed

For the first time, a Texas jury has decided the pelvic mesh made by healthcare giant Johnson & Johnson was defectively designed .

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

Wed Apr 16, 2014

Courier News

Frankie Valli to headline State Theatre benefit gala

"Walk Like A Man" to the State Theatre in New Brunswick on Saturday, May 17. Frankie Valli and the Four Seasons are the headliners of the State's annual benefit gala concert.

Comment?

Related Topix: New Brunswick, NJ, Frankie Valli & the Four Seasons, Rock-N-Roll, The Four Seasons, Oldies, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

AmericanBankingNews.com

Johnson & Johnson's Underperform Rating Reaffirmed at Credit Suisse

's stock had its "underperform" rating reiterated by equities research analysts at Credit Suisse in a research note issued to investors on Wednesday, Analyst Ratings News reports.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

The Motley Fool

Johnson and Johnson Earnings Surprises With Blockbuster Potential

Editor's Note: In the video below, Olysio's sales for the quarter are identified as $365 million.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

ABC News

Smartphone Apps to Help Patients Take Their Meds

Several smartphone apps are available to help patients take their medications as prescribed.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

MarketWatch

Stocks gain for 2nd day in row after Ukraine fears ease

U.S. stocks closed higher Tuesday following a choppy session, bouncing back from a sizable drop that came after reports of fighting on the ground in Ukraine.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry, World News, Ukraine

The New Zealand Herald

NZ shares joined global rally

New Zealand stocks joined a global rally as US company earnings growth lifted sentiment for equity markets.

Comment?

Related Topix: Financial Markets, Beverages, CocaCola, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••